Skip to content
TrialScanner

NCT00665145

Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

Phase 2CompletedSGMOQLead

Registry record

Lead sponsor
Sangamo Therapeutics
Conditions
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy
Primary completion
Oct 2009Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00665145 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00665145: Stem Cell Mobilization in... | TrialScanner